Inspire Medical Systems Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for Inspire Medical Systems stock have an average target of 127.07, with a low estimate of 82 and a high estimate of 216. The average target predicts a decrease of -7.12% from the current stock price of 136.81.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$82	$127.07	$125	$216
Change	-40.06%	-7.12%	-8.63%	+57.88%

Analyst Ratings

The average analyst rating for Inspire Medical Systems stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	3	2	2	3	3
Buy	7	5	6	6	7	6
Hold	3	6	7	8	5	6
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	14	15	16	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mike Polark Baird	Baird	Buy Maintains $125 → $180	Buy	Maintains	$125 → $180	+31.57%	Dec 4, 2025
Kallum Titchmarsh Morgan Stanley	Morgan Stanley	Buy → Hold Downgrades $105 → $130	Buy → Hold	Downgrades	$105 → $130	-4.98%	Dec 2, 2025
Richard Newitter Truist Securities	Truist Securities	Hold → Strong Buy Upgrades $128 → $165	Hold → Strong Buy	Upgrades	$128 → $165	+20.61%	Nov 26, 2025
Mike Polark Wolfe Research	Wolfe Research	Hold → Buy Upgrades $180	Hold → Buy	Upgrades	$180	+31.57%	Nov 25, 2025
Jonathan Block Stifel	Stifel	Hold → Strong Buy Upgrades $100 → $110	Hold → Strong Buy	Upgrades	$100 → $110	-19.60%	Nov 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

922.98M

from 802.80M

14.97%

from 802.80M

Revenue Next Year

1.03B

from 922.98M

11.81%

from 922.98M

EPS This Year

0.94

from 1.75

-46.56%

from 1.75

EPS Next Year

1.74

from 0.94

86.52%

from 0.94

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	115.38M	233.39M	407.86M	624.80M	802.80M	922.98M	1.03B
Revenue Growth	40.62%	102.28%	74.75%	53.19%	28.49%	14.97%	11.81%
EPS	-2.19	-1.54	-1.60	-0.72	1.75	0.94	1.74
EPS Growth	-	-	-	-	-	-46.56%	86.52%
Forward PE	-	-	-	-	-	146.30	78.44
No. Analysts	-	-	-	-	-	22	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	954.0M	1.1B
Avg	923.0M	1.0B
Low	882.0M	976.1M

Revenue Growth

Revenue Growth	2025	2026
High	18.8%	21.7%
Avg	15.0%	11.8%
Low	9.9%	5.8%

EPS Forecast

EPS	2025	2026
High	1.65	2.57
Avg	0.94	1.74
Low	0.43	0.92

EPS Growth

EPS Growth	2025	2026
High	-5.8%	175.1%
Avg	-46.6%	86.5%
Low	-75.4%	-1.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.